684 related articles for article (PubMed ID: 11974560)
1. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
Baracat EC; Barbosa IC; Giordano MG; Haidar MA; Marinho RM; Menegocci JC; Morais KM; Tomaz G; Wehba S
Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
[TBL] [Abstract][Full Text] [Related]
2. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
[TBL] [Abstract][Full Text] [Related]
3. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
Odmark IS; Carlström K; Jonsson B; Jonasson AF
Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
[TBL] [Abstract][Full Text] [Related]
4. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
Bots ML; Evans GW; Riley W; McBride KH; Paskett ED; Helmond FA; Grobbee DE;
Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304
[TBL] [Abstract][Full Text] [Related]
5. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
Pan HA; Wang ST; Pai MC; Chen CH; Wu MH; Huang KE
J Reprod Med; 2003 May; 48(5):375-80. PubMed ID: 12815913
[TBL] [Abstract][Full Text] [Related]
6. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
[TBL] [Abstract][Full Text] [Related]
7. An open-label study of subdermal implants of estradiol-only versus subdermal implants of estradiol plus nomegestrol acetate: effects on symptom control, lipid profile and tolerability.
Barbosa IC; Coutinho EM; Oladapo L; Noronha CF; Mota RL; Lopes AC; Lopes RC
Gynecol Endocrinol; 2009 Apr; 25(4):269-75. PubMed ID: 19408176
[TBL] [Abstract][Full Text] [Related]
8. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
9. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
Skouby SO; Sidelmann JJ; Nilas L; Jespersen J
Hum Reprod; 2007 Apr; 22(4):1186-91. PubMed ID: 17204528
[TBL] [Abstract][Full Text] [Related]
11. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
Ziaei S; Moghasemi M; Faghihzadeh S
Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
[TBL] [Abstract][Full Text] [Related]
13. The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
Skouby SO; Sidelmann JJ; Nilas L; Gram J; Jespersen J
Climacteric; 2008; 11(6):489-97. PubMed ID: 18991076
[TBL] [Abstract][Full Text] [Related]
14. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
Archer DF; Pickar JH; Bottiglioni F
Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
[TBL] [Abstract][Full Text] [Related]
15. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
Uygur D; Yeşildaglar N; Erkaya S
Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
Ziaei S; Moaya M; Faghihzadeh S
Climacteric; 2010 Jun; 13(3):249-53. PubMed ID: 19848555
[TBL] [Abstract][Full Text] [Related]
17. Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women.
Valdivia I; Campodónico I; Tapia A; Capetillo M; Espinoza A; Lavín P
Fertil Steril; 2004 Mar; 81(3):617-23. PubMed ID: 15037411
[TBL] [Abstract][Full Text] [Related]
18. Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women.
Inan I; Kelekci S; Yilmaz B
Gynecol Endocrinol; 2005 Feb; 20(2):64-7. PubMed ID: 15823823
[TBL] [Abstract][Full Text] [Related]
19. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
20. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
Diaby V; Perreault S; Lachaine J
Maturitas; 2007 Oct; 58(2):138-49. PubMed ID: 17870259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]